Abstract
Background and objectives
Endovascular thrombectomy (EVT) for large vessel occlusion ischaemic stroke is either performed under general anesthesia (GA) or with non-GA techniques such as conscious sedation (CS) or local anesthesia (LA) alone. Previous small meta-analyses have demonstrated superior recanalization rates and improved functional recovery with GA compared with non-GA techniques. The publication of further RCTs could provide updated guidance when choosing between GA and non-GA techniques.
Methods
A systematic search for trials in which stroke EVT patients were randomised to GA or non-GA was performed in Medline, Embase and the Cochrane Central Register of Controlled Trials. A systematic review and meta-analysis using a random effects model was performed.
Results
Seven RCTs were included in the systematic review and meta-analysis. These trials included a total of 980 participants (GA, N=487; non-GA, N=493). GA improves recanalization by 9.0% (GA 84.6 % versus non-GA 75.6%; OR=1.75, 95% CI 1.26 to 2.42, P=0.0009) and the proportion of patients with functional recovery improves by 8.4% (GA 44.6 % versus non-GA 36.2%; OR=1.43, 95% CI 1.04 to 1.98, P=0.03). There was no difference in hemorrhagic complications or 3 month mortality.
Conclusions
In ischemic stroke patients treated with EVT, general anesthesia (GA) is associated with higher recanalization rates and improved functional recovery at 3 months compared with non-GA techniques. Conversion to GA and subsequent intention to treat analysis will underestimate the true therapeutic benefit. GA is established as effective in improving recanalization rates in EVT (7 Class 1 studies) with a high GRADE certainty rating. GA is established as effective in improving functional recovery at 3 months in EVT (5 Class 1 studies) with a moderate GRADE certainty rating. Stroke services need to develop pathways to incorporate GA as the first choice for most endovascular thrombectomy procedures in acute ischemic stroke with a level A recommendation for recanalization and level B recommendation for functional recovery.
- Received June 20, 2022.
- Accepted in final form January 3, 2023.
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken